BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

250 related articles for article (PubMed ID: 3304711)

  • 61. Mass concentration and activity concentration of creatine kinase isoenzyme MB compared in serum after acute myocardial infarction.
    Delanghe JR; De Mol AM; De Buyzere ML; De Scheerder IK; Wieme RJ
    Clin Chem; 1990 Jan; 36(1):149-53. PubMed ID: 2404640
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Bioluminescence assay of creatine kinase and its isoenzymes in serum and cerebrospinal fluid.
    Tarkkanen P; Komor S; Cornely C; Hacke W; Greiling H
    Clin Chem; 1979 Sep; 25(9):1644-8. PubMed ID: 466791
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Analytical evaluation of the CK-MB mass assay on the Technicon Immuno 1 system.
    Lévesque A; Letellier M; Grant A
    Clin Biochem; 1997 Feb; 30(1):11-6. PubMed ID: 9056104
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Macro creatine kinase BB in serum, and some data on its prevalence.
    Urdal P; Landaas S
    Clin Chem; 1979 Mar; 25(3):461-5. PubMed ID: 262189
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Quantification of creatine kinase BB isoenzyme in tumor cytosols and serum with an ultrasensitive time-resolved immunofluorometric technique.
    Zarghami N; Yu H; Diamandis EP; Sutherland DJ
    Clin Biochem; 1995 Jun; 28(3):243-53. PubMed ID: 7554242
    [TBL] [Abstract][Full Text] [Related]  

  • 66. [Evaluation of the latex turbidimetric immunoassay for CK-MB protein].
    Okubo M; Kimura S; Matsui M; Suehisa E; Hidaka Y
    Rinsho Byori; 2013 Nov; 61(11):989-94. PubMed ID: 24450103
    [TBL] [Abstract][Full Text] [Related]  

  • 67. [The current aspect of serum creatine kinase in the laboratory medicine].
    Uzawa R
    Rinsho Byori; 1990 Mar; 38(3):282-7. PubMed ID: 2190026
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Elevation of creatine kinase BB CK in hospitalized patients. Importance of distinguishing BB CK from MB CK.
    Apple FS; Greenspan NS; Dietzler DN
    Ann Clin Lab Sci; 1982; 12(5):398-402. PubMed ID: 7137935
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Human heart-type cytoplasmic fatty acid-binding protein (H-FABP) for the diagnosis of acute myocardial infarction. Clinical evaluation of H-FABP in comparison with myoglobin and creatine kinase isoenzyme MB.
    Okamoto F; Sohmiya K; Ohkaru Y; Kawamura K; Asayama K; Kimura H; Nishimura S; Ishii H; Sunahara N; Tanaka T
    Clin Chem Lab Med; 2000 Mar; 38(3):231-8. PubMed ID: 10905760
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Automated creatine kinase-MB estimation by immuno-inhibition: a clinical evaluation.
    Delahunty TJ; Foreback CC
    Clin Chem; 1980 Apr; 26(5):568-72. PubMed ID: 7020990
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Evaluation of the chemiluminescence immunoassays for the measurement of troponin I, myoglobin and CK-MB using the IMMULITE system in comparison to other measuring systems.
    Lestin M; Hergert M; Lestin HG; Brinker C; Storm H; Kuhrt E; Kuhrt B; Lambrecht HG; Kühnel W
    Clin Lab; 2002; 48(3-4):211-21. PubMed ID: 11934224
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Macro creatine kinases: results of isoenzyme electrophoresis and differentiation of the immunoglobulin-bound type by radioassay.
    Bohner J; Stein W; Steinhart R; Würzburg U; Eggstein M
    Clin Chem; 1982 Apr; 28(4 Pt 1):618-23. PubMed ID: 7074829
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Results of a nationwide survey of analyses for creatine kinase and creatine kinase isoenzymes.
    Boone DJ; Duncan PH; MacNeil ML; Smith BF; Houston B; Hearn TL
    Clin Chem; 1984 Jan; 30(1):33-7. PubMed ID: 6690148
    [TBL] [Abstract][Full Text] [Related]  

  • 74. False-positive troponin I in the MEIA due to the presence of rheumatoid factors in serum. Elimination of this interference by using a polyclonal antisera against rheumatoid factors.
    Dasgupta A; Banerjee SK; Datta P
    Am J Clin Pathol; 1999 Dec; 112(6):753-6. PubMed ID: 10587696
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Circulating CK-MB and CK-BB isoenzymes after prostate resection.
    Kimler SC; Sandhu RS
    Clin Chem; 1980 Jan; 26(1):55-9. PubMed ID: 7356573
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Isoenzyme-directed selection and characterization of anti-creatine kinase single chain Fv antibodies from a human phage display library.
    Schlattner U; Reinhart C; Hornemann T; Tokarska-Schlattner M; Wallimann T
    Biochim Biophys Acta; 2002 Dec; 1579(2-3):124-32. PubMed ID: 12427547
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Clinical laboratory investigation of the Sanofi ACCESS CK-MB procedure and comparison to electrophoresis and Abbott IMx.
    Mao GD; Adeli K; Eisenbrey AB; Artiss JD
    Am J Clin Pathol; 1996 Jul; 106(1):112-7. PubMed ID: 8701919
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Reliability and significance of increased creatine kinase MB isoenzyme in the serum of uremic patients.
    Medeiros LJ; Schotte D; Gerson B
    Am J Clin Pathol; 1987 Jan; 87(1):103-8. PubMed ID: 3799540
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Stability of the CK-MB isoenzyme on routine storage.
    Buttery JE; Stuart S; Pannall PR
    Clin Biochem; 1992 Feb; 25(1):11-3. PubMed ID: 1551236
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Macro-creatine kinase as an interference in CK isoenzyme determinations.
    Devine JE
    Enzyme; 1983; 30(2):139-44. PubMed ID: 6617627
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.